193 related articles for article (PubMed ID: 30914429)
21. Corosolic Acid Attenuates the Invasiveness of Glioblastoma Cells by Promoting CHIP-Mediated AXL Degradation and Inhibiting GAS6/AXL/JAK Axis.
Sun LW; Kao SH; Yang SF; Jhang SW; Lin YC; Chen CM; Hsieh YH
Cells; 2021 Oct; 10(11):. PubMed ID: 34831142
[TBL] [Abstract][Full Text] [Related]
22. Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.
Müller J; Krijgsman O; Tsoi J; Robert L; Hugo W; Song C; Kong X; Possik PA; Cornelissen-Steijger PD; Geukes Foppen MH; Kemper K; Goding CR; McDermott U; Blank C; Haanen J; Graeber TG; Ribas A; Lo RS; Peeper DS
Nat Commun; 2014 Dec; 5():5712. PubMed ID: 25502142
[TBL] [Abstract][Full Text] [Related]
23. PI3Kβ links integrin activation and PI(3,4)P
Erami Z; Heitz S; Bresnick AR; Backer JM
Mol Biol Cell; 2019 Aug; 30(18):2367-2376. PubMed ID: 31318314
[TBL] [Abstract][Full Text] [Related]
24. Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion.
Cortesio CL; Chan KT; Perrin BJ; Burton NO; Zhang S; Zhang ZY; Huttenlocher A
J Cell Biol; 2008 Mar; 180(5):957-71. PubMed ID: 18332219
[TBL] [Abstract][Full Text] [Related]
25. Serine-Threonine Kinase TAO3-Mediated Trafficking of Endosomes Containing the Invadopodia Scaffold TKS5α Promotes Cancer Invasion and Tumor Growth.
Iizuka S; Quintavalle M; Navarro JC; Gribbin KP; Ardecky RJ; Abelman MM; Ma CT; Sergienko E; Zeng FY; Pass I; Thomas GV; McWeeney SK; Hassig CA; Pinkerton AB; Courtneidge SA
Cancer Res; 2021 Mar; 81(6):1472-1485. PubMed ID: 33414172
[TBL] [Abstract][Full Text] [Related]
26. CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Hoffmann C; Mao X; Dieterle M; Moreau F; Al Absi A; Steinmetz A; Oudin A; Berchem G; Janji B; Thomas C
Oncotarget; 2016 Mar; 7(12):13688-705. PubMed ID: 26883198
[TBL] [Abstract][Full Text] [Related]
27. AXL-Driven EMT State as a Targetable Conduit in Cancer.
Antony J; Huang RY
Cancer Res; 2017 Jul; 77(14):3725-3732. PubMed ID: 28667075
[TBL] [Abstract][Full Text] [Related]
28. Protein dynamics at invadopodia control invasion-migration transitions in melanoma cells.
Legrand M; Mousson A; Carl P; Rossé L; Justiniano H; Gies JP; Bouvard D; Sick E; Dujardin D; Rondé P
Cell Death Dis; 2023 Mar; 14(3):190. PubMed ID: 36899008
[TBL] [Abstract][Full Text] [Related]
29. AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network.
Abu-Thuraia A; Goyette MA; Boulais J; Delliaux C; Apcher C; Schott C; Chidiac R; Bagci H; Thibault MP; Davidson D; Ferron M; Veillette A; Daly RJ; Gingras AC; Gratton JP; Côté JF
Nat Commun; 2020 Jul; 11(1):3586. PubMed ID: 32681075
[TBL] [Abstract][Full Text] [Related]
30. A TAZ-AXL-ABL2 Feed-Forward Signaling Axis Promotes Lung Adenocarcinoma Brain Metastasis.
Hoj JP; Mayro B; Pendergast AM
Cell Rep; 2019 Dec; 29(11):3421-3434.e8. PubMed ID: 31825826
[TBL] [Abstract][Full Text] [Related]
31. Activation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors: suggestion of combination therapy.
Torka R; Pénzes K; Gusenbauer S; Baumann C; Szabadkai I; Őrfi L; Kéri G; Ullrich A
Neoplasia; 2014 Apr; 16(4):301-18. PubMed ID: 24862757
[TBL] [Abstract][Full Text] [Related]
32. Quantification of Invadopodia Formation and Matrix Degradation Activity.
Venghateri JB; Geiger B
Methods Mol Biol; 2023; 2600():185-196. PubMed ID: 36587098
[TBL] [Abstract][Full Text] [Related]
33. Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells.
Pénzes K; Baumann C; Szabadkai I; Orfi L; Kéri G; Ullrich A; Torka R
Cancer Biol Ther; 2014; 15(11):1571-82. PubMed ID: 25482942
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma.
Song X; Wang H; Logsdon CD; Rashid A; Fleming JB; Abbruzzese JL; Gomez HF; Evans DB; Wang H
Cancer; 2011 Feb; 117(4):734-43. PubMed ID: 20922806
[TBL] [Abstract][Full Text] [Related]
35. The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.
Uribe DJ; Mandell EK; Watson A; Martinez JD; Leighton JA; Ghosh S; Rothlin CV
PLoS One; 2017; 12(7):e0179979. PubMed ID: 28727830
[TBL] [Abstract][Full Text] [Related]
36. Arg kinase mediates CXCL12/CXCR4-induced invadopodia formation and invasion of glioma cells.
Chen L; Zhu M; Yu S; Hai L; Zhang L; Zhang C; Zhao P; Zhou H; Wang S; Yang X
Exp Cell Res; 2020 Apr; 389(1):111893. PubMed ID: 32035133
[TBL] [Abstract][Full Text] [Related]
37. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.
Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO
Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455
[TBL] [Abstract][Full Text] [Related]
38. Actinin-1 and actinin-4 play essential but distinct roles in invadopodia formation by carcinoma cells.
Yamaguchi H; Ito Y; Miura N; Nagamura Y; Nakabo A; Fukami K; Honda K; Sakai R
Eur J Cell Biol; 2017 Oct; 96(7):685-694. PubMed ID: 28797528
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer.
Yeh CY; Shin SM; Yeh HH; Wu TJ; Shin JW; Chang TY; Raghavaraju G; Lee CT; Chiang JH; Tseng VS; Lee YC; Shen CH; Chow NH; Liu HS
BMC Cancer; 2011 Apr; 11():139. PubMed ID: 21496277
[TBL] [Abstract][Full Text] [Related]
40. EP4 receptor promotes invadopodia and invasion in human breast cancer.
Tönisen F; Perrin L; Bayarmagnai B; van den Dries K; Cambi A; Gligorijevic B
Eur J Cell Biol; 2017 Mar; 96(2):218-226. PubMed ID: 28094049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
